A. Larsson
- Respiratory critical care HERMES: a European core syllabus in respiratory critical care medicineBy A. Artigas, T. Vassilakopoulos, L. Brochard, D. Dellweg, A. Farr, M. Ferrer, J. Geiseler, A. Larsson, S. Nava, P. Navalesi, J-L Noël, S. Orfanos, P. Palange, B. Schoenhofer, A. Simonds and P. PelosiA. ArtigasEducational Activities, ERS Headquarters 4, Avenue Ste-Luce, CH 1003 Lausanne, SwitzerlandT. VassilakopoulosEducational Activities, ERS Headquarters 4, Avenue Ste-Luce, CH 1003 Lausanne, SwitzerlandL. BrochardEducational Activities, ERS Headquarters 4, Avenue Ste-Luce, CH 1003 Lausanne, SwitzerlandD. DellwegEducational Activities, ERS Headquarters 4, Avenue Ste-Luce, CH 1003 Lausanne, SwitzerlandA. FarrEducational Activities, ERS Headquarters 4, Avenue Ste-Luce, CH 1003 Lausanne, SwitzerlandM. FerrerEducational Activities, ERS Headquarters 4, Avenue Ste-Luce, CH 1003 Lausanne, SwitzerlandJ. GeiselerEducational Activities, ERS Headquarters 4, Avenue Ste-Luce, CH 1003 Lausanne, SwitzerlandA. LarssonEducational Activities, ERS Headquarters 4, Avenue Ste-Luce, CH 1003 Lausanne, SwitzerlandS. NavaEducational Activities, ERS Headquarters 4, Avenue Ste-Luce, CH 1003 Lausanne, SwitzerlandP. NavalesiEducational Activities, ERS Headquarters 4, Avenue Ste-Luce, CH 1003 Lausanne, SwitzerlandJ-L NoëlEducational Activities, ERS Headquarters 4, Avenue Ste-Luce, CH 1003 Lausanne, SwitzerlandS. OrfanosEducational Activities, ERS Headquarters 4, Avenue Ste-Luce, CH 1003 Lausanne, SwitzerlandP. PalangeEducational Activities, ERS Headquarters 4, Avenue Ste-Luce, CH 1003 Lausanne, SwitzerlandB. SchoenhoferEducational Activities, ERS Headquarters 4, Avenue Ste-Luce, CH 1003 Lausanne, SwitzerlandA. SimondsEducational Activities, ERS Headquarters 4, Avenue Ste-Luce, CH 1003 Lausanne, SwitzerlandP. PelosiEducational Activities, ERS Headquarters 4, Avenue Ste-Luce, CH 1003 Lausanne, Switzerland
- Free, soluble interleukin-17 protein during severe inflammation in human airwaysBy M. Laan, L. Palmberg, K. Larsson and A. LindénM. LaanL. PalmbergK. Larsson
- Passive smoking and respiratory symptoms in the FinEsS StudyBy M.L. Larsson, H-M. Loit, M. Meren, J. Põlluste, A. Magnusson, K. Larsson and B. LundbäckM.L. LarssonH-M. LoitM. MerenJ. PõllusteA. MagnussonK. Larsson
- Epidemiological aspects and early detection of chronic obstructive airway diseases in the elderlyBy B. Lundbäck, A. Gulsvik, M. Albers, P. Bakke, E. Rönmark, G. van den Boom, J. Brøgger, L‐G. Larsson, I. Welle, C. van Weel and E. OmenaasB. LundbäckA. GulsvikM. AlbersP. BakkeE. RönmarkG. van den BoomJ. BrøggerL‐G. LarssonI. WelleC. van Weel
- The effect of fluticasone on the airway inflammatory response to organic dustBy A. Ek, L. Palmberg and K. LarssonA. EkL. Palmberg
- Negligible clearance of ultrafine particles retained in healthy and affected human lungsBy P. Wiebert, A. Sanchez-Crespo, J. Seitz, R. Falk, K. Philipson, W. G. Kreyling, W. Möller, K. Sommerer, S. Larsson and M. SvartengrenP. WiebertA. Sanchez-CrespoJ. SeitzR. FalkK. PhilipsonW. G. KreylingW. MöllerK. SommererS. Larsson
- Road tunnel air pollution induces bronchoalveolar inflammation in healthy subjectsBy B-M. Larsson, M. Sehlstedt, J. Grunewald, C. M. Sköld, A. Lundin, A. Blomberg, T. Sandström, A. Eklund and M. SvartengrenB-M. LarssonM. SehlstedtJ. GrunewaldC. M. SköldA. LundinA. BlombergT. SandströmA. Eklund
- Health effects of a subway environment in healthy volunteersBy A. Klepczyńska Nyström, M. Svartengren, J. Grunewald, C. Pousette, I. Rödin, A. Lundin, C.M. Sköld, A. Eklund and B-M. LarssonA. Klepczyńska NyströmM. SvartengrenJ. GrunewaldC. PousetteI. RödinA. LundinC.M. SköldA. Eklund
- TOF-SIMS analysis of exhaled particles from patients with asthma and healthy controlsBy A-C. Almstrand, M. Josefson, A. Bredberg, J. Lausmaa, P. Sjövall, P. Larsson and A-C. OlinA-C. AlmstrandM. JosefsonA. BredbergJ. LausmaaP. SjövallP. Larsson
- Distribution of vitamin C transporters in the lower airways of humansBy G.D. Rankin, N. Larsson, E. Roos-Engstrand, J. Pourazar, A. Blomberg, I. Mudway and A.F. BehndigG.D. Rankin1Department of Public Health and Clinical Medicine, Umeå University, Umeå, SwedenN. Larsson1Department of Public Health and Clinical Medicine, Umeå University, Umeå, SwedenE. Roos-Engstrand1Department of Public Health and Clinical Medicine, Umeå University, Umeå, SwedenJ. Pourazar1Department of Public Health and Clinical Medicine, Umeå University, Umeå, SwedenA. Blomberg1Department of Public Health and Clinical Medicine, Umeå University, Umeå, SwedenI. Mudway2MRC-HPA Centre for Environment and Health, King's College London, London, United KingdomA.F. Behndig1Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden
- Associated factors with persistent airflow limitation in asthma in U-BIOPREDBy A. Wagener, D. Gibeon, X. Yang, A. Sousa, J. Corfield, D. Shaw, S. Fowler, L. Fleming, J. Riley, L. Jeyasingham, A. Rowe, K. Fichtner, G. Roberts, P. Bakke, F. Singer, T. Geiser, U. Frey, I. Horvarth, R. Polosa, K. Bønnelykke, N. Krug, R. Middelveld, S.-E. Dahlen, B. Dahlen, G. Hedlin, S. Hashimoto, B. Nordlund, J. Musial, A. Woodcock, C. Murray, L. Pahus, P. Chanez, D. Myles, C. Compton, T.W. Higenbottam, P. Montuschi, J. Vestbo, L. Larsson, T. Sandstrom, H. Bisgaard, S.S. Wagers, P.H. Howarth, E.H. Bel, R. Djukanovic, F. Chung and P. SterkA. Wagener2Academic Medical Centre, University of Amsterdam, Amsterdam, NetherlandsD. Gibeon1NHLI, Imperial College London, London, United KingdomX. Yang1NHLI, Imperial College London, London, United KingdomA. Sousa3Respiratory Therapy Unit, GlaxoSmithKline, London, United KingdomJ. Corfield4Clinical Research, AstraZeneca, Lund, SwedenD. Shaw5Nottingham Respiratory Research Unit, Nottingham City Hospital, Nottingham, United KingdomS. Fowler6Respiratory Medicine, University of Manchester and Lancashire Teaching Hospitals NHS Foundation Trust, Manchester, United KingdomL. Fleming1NHLI, Imperial College London, London, United KingdomJ. Riley3Respiratory Therapy Unit, GlaxoSmithKline, London, United KingdomL. Jeyasingham3Respiratory Therapy Unit, GlaxoSmithKline, London, United KingdomA. Rowe7External Innovation, R&D IT, Janssen Research and Development, London, United KingdomK. Fichtner8Global Clinical Operations, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, United KingdomG. Roberts9Faculty of Medicine, University of Southampton, Southampton, United KingdomP. Bakke10Respiratory Medicine, Haukeland University Hospital, Bergen, NorwayF. Singer11Respiratory Medicine, Inselspital and University of Bern, Bern, SwitzerlandT. Geiser11Respiratory Medicine, Inselspital and University of Bern, Bern, SwitzerlandU. Frey11Respiratory Medicine, Inselspital and University of Bern, Bern, SwitzerlandI. Horvarth12Department of Pulmonology, Semmelweis University, Budapest, United KingdomR. Polosa13Medicine and Immunology Clinic, University of Catania, Catania, ItalyK. Bønnelykke14University Hospital, University Hospital, Copenhagen, Copenhagen, DenmarkN. Krug15Medicine, Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, GermanyR. Middelveld16The Centre for Allergy Research, Karolinska Insitute, Stockholm, SwedenS.-E. Dahlen16The Centre for Allergy Research, Karolinska Insitute, Stockholm, SwedenB. Dahlen16The Centre for Allergy Research, Karolinska Insitute, Stockholm, SwedenG. Hedlin16The Centre for Allergy Research, Karolinska Insitute, Stockholm, SwedenS. Hashimoto2Academic Medical Centre, University of Amsterdam, Amsterdam, NetherlandsB. Nordlund16The Centre for Allergy Research, Karolinska Insitute, Stockholm, SwedenJ. Musial17Medical College, Jagiellonian University, Krakow, PolandA. Woodcock6Respiratory Medicine, University of Manchester and Lancashire Teaching Hospitals NHS Foundation Trust, Manchester, United KingdomC. Murray6Respiratory Medicine, University of Manchester and Lancashire Teaching Hospitals NHS Foundation Trust, Manchester, United KingdomL. Pahus18Hopital Nord, Bureau De Recherche Clinique, Université De La Méditerranee, Marseille, FranceP. Chanez18Hopital Nord, Bureau De Recherche Clinique, Université De La Méditerranee, Marseille, FranceD. Myles3Respiratory Therapy Unit, GlaxoSmithKline, London, United KingdomC. Compton19Horsham Research Center, Novartis Pharma AG, Horsham, United KingdomT.W. Higenbottam20Chiesi Research, Chiesi, London, United KingdomP. Montuschi21Istituto Di Farmacologia, Università Cattolica Del Sacro Cuore, Rome, ItalyJ. Vestbo22Lungemedicinsk Sektion, Hvidovre Hospital, Hvidovre, DenmarkL. Larsson4Clinical Research, AstraZeneca, Lund, SwedenT. Sandstrom23Respiratory and Allergy Division, University Hospital, Umeå, Umeå, SwedenH. Bisgaard14University Hospital, University Hospital, Copenhagen, Copenhagen, DenmarkS.S. Wagers24BioSci Consulting, BioSci Consulting, Maasmechelen, BelgiumP.H. Howarth9Faculty of Medicine, University of Southampton, Southampton, United KingdomE.H. Bel2Academic Medical Centre, University of Amsterdam, Amsterdam, NetherlandsR. Djukanovic9Faculty of Medicine, University of Southampton, Southampton, United KingdomF. Chung1NHLI, Imperial College London, London, United KingdomP. Sterk2Academic Medical Centre, University of Amsterdam, Amsterdam, Netherlands
- Road tunnel air pollution induces bronchoalveolar inflammation in healthy subjectsBy B-M. Larsson, M. Sehlstedt, J. Grunewald, C.M. Sköld, A. Lundin, A. Blomberg, T. Sandström, A. Eklund and M. SvartengrenArticle | Published in 2007 in European Respiratory JournalB-M. LarssonM. SehlstedtJ. GrunewaldC.M. SköldA. LundinA. BlombergT. SandströmA. Eklund
- TOF-SIMS analysis of exhaled particles from patients with asthma and healthy controlsBy A-C. Almstrand, M. Josefson, A. Bredberg, J. Lausmaa, P. Sjövall, P. Larsson and A-C. OlinArticle | Published in 2011 in European Respiratory JournalA-C. AlmstrandM. JosefsonA. BredbergJ. LausmaaP. SjövallP. Larsson
- Negligible clearance of ultrafine particles retained in healthy and affected human lungsBy P. Wiebert, A. Sanchez-Crespo, J. Seitz, R. Falk, K. Philipson, W.G. Kreyling, W. Möller, K. Sommerer, S. Larsson and M. SvartengrenArticle | Published in 2006 in European Respiratory JournalP. WiebertA. Sanchez-CrespoJ. SeitzR. FalkK. PhilipsonW.G. KreylingW. MöllerK. SommererS. Larsson
- Health effects of a subway environment in healthy volunteers. Experimental dataBy A.K. Nyström, M. Svartengren, J. Grunewald, C. Pousette, I. Rödin, A. Lundin, C.M. Sköld, A. Eklund and B-M. LarssonArticle | Published in 2009 in European Respiratory JournalA.K. NyströmM. SvartengrenJ. GrunewaldC. PousetteI. RödinA. LundinC.M. SköldA. Eklund
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.